Prev：Bioactive ROS-Responsive Nanotherapeutics Attenuate Intermittent Hypoxia-Induced Cognitive Impairment via NRF2/KEAP1/HO-1 Signaling.(A23620-4.000)
Next：Engineered Mesenchymal Stem Cell–Derived Extracellular Vesicles Reverse Endothelial–Mesenchymal Transition in Atherosclerosis.(A23620-14.500)
